FISH detection of mixed chimerism in 33 patients submitted to bone marrow transplantation

Bone Marrow Transplantation

Volumn 17, Issue 2, 1996, Pages 231-236

  Palka, G ^a,d   Stuppia, L ^b   Di Bartolomeo, P ^c   Morizio, E ^a   Peila, R ^b   Guanciali Franchi, P ^a   Calabrese, G ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b CNR   (Italy)

^c Ospedale Civile di Pescara   (Italy)

^d NONE   (Italy)

Author keywords

Chimerism; FISH; Minimal residual disease

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHIMERA; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE REARRANGEMENT; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; INTERPHASE; MALE; MINIMAL RESIDUAL DISEASE; ONCOGENE; PRIORITY JOURNAL; REMISSION; WHOLE BODY RADIATION; X CHROMOSOME; Y CHROMOSOME;

EID: 0030063858     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Haase OA, Hinterberger W, Schmidmeier W et al. Cytogenetic studies in bone marrow transplant recipients. Blut 1986; 53: 29-38.
2. Hill RS, Petersen FE, Storb R et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft versus host disease. Blood 1986; 67: 811-816.
3. Petz LD, Yam P, Wallace RB et al. Mixed haematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood 1987; 70: 1331-1337.
4. Durnam DM, Anders KR, Fisher L et al. Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood 1989; 74: 2220-2226.
5. Stuppia L, Calabrese G, Guanciali Franchi P et al. Detection of minimal residual disease by polymerase chain reaction in patients with different hematologic diseases treated by bone marrow transplantation. Cancer Genet Cytogenet 1993; 65: 88-92.
6. Viard F. Merel P, Bilhou-Nabera C et al. Mixed chimerism after sex-mismatched allogeneic BMT: evaluation of two molecular techniques. Bone Marrow Transplant 1993; 11: 27-31.
7. Palka G, Di Bartolomeo P, Iacone A et al. Cytogenetics and bone marrow transplantation. Cancer Genet Cytogenet 1986; 21: 147-157.
8. Becher R, Beelen DW, Mahmoud HK, Schaefer UW. Cytogenetics and bone marrow transplantation. In: Becher R, Sandberg AA. Schmidt CG (eds). Chromosome in Hematology. Zuckeschwerd: San Francisco, 1986. pp 58-67.
9. Cooperative study group on chromosome in transplanted patients. Cytogenetic follow-up of 100 patients submitted to bone marrow transplantation for Philadelphia chromosome-positive chronic myeloid leukemia. Eur J Haematol 1988; 40: 50-57.
10. Calabrese G, Di Bartolomeo P, Stuppia L et al. Cytogenetics in patients with chronic myelogenous leukemia treated with bone marrow transplantation. Cancer Genet Cytogenet 1989; 41: 49-59.
11. Palka G, Calabrese G. Di Bartolomeo G et al. Cytogenetic survey of 31 patients treated with bone marrow transplantation for acute nonlymphocytic and acute lymphoblastic leukemias. Cancer Genet Cytogenet 1991; 51: 223-233.
12. Zemanova Z, Michalova K, Musilova J et al. Sequential cytogenetic study of patients after bone marrow transplantation. Cancer Genet Cytogenet 1994; 72: 68-72.
13. Wessman M, Popp S, Ruutu T et al. Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization and karyotype analysis. Bone Marrow Transplant 1993; 11: 279-284.
14. Lawler M. McCann SR, De Arce MA, Humphries P. A rapid dot blot assay to assess chimerism following sex mismatched bone marrow transplantation. Bone Marrow Transplant 1988; 3: 437-482.
15. Hutchinson RM, Pringle JH, Potter L et al. Rapid identification of donor and recipient cells after allogeneic bone marrow transplantation using specific genetic markers. Br J Haematol 1989; 72: 133-140.
16. Amiel A, Yarkoni S. Fejgin M et al. Clinical detection of BCR-ABL fusion by in situ hybridization in chronic myelogenous leukemia. Cancer Genet Cytogenet 1993; 65: 32-34.
17. Crescenzi M, Seto M, Herzig GP et al. Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA 1989; 85: 4869-4873.
18. Lawler M, McCann SR, Conneally E, Humpries P. Chimerism following allogeneic bone marrow transplantation: detection of residual host cells using the polymerase chain reaction. Br J Haematol 1989; 73: 205-210.
19. Gabert J, Lafage M, Maraninchi D et al. Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation. Lancet 1989; ii: 1125-1128.
20. Morgan GJ, Janssen JWG, Guo AP et al. Polymerase chain reaction for detection of residual leukemia. Lancet 1989; i: 928-929.
21. Lawler M, Humphries P, McCann SR. Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequence using the polymerase chain reaction. Blood 1991; 77: 2504-2514.
22. Ugozzoli L, Yam LD, Petz GB et al. Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood 1991; 77: 1607-1615.
23. Poddighe PJ, Moesker O, Smeets D et al. Interphase cytogenetics of hematological cancer: comparison of classical karyotyping and in situ hybridization using a panel of eleven chromosome specific DNA probes. Cancer Res 1991; 51: 1959-1967.
24. Dewald GW, Schad CR, Christensen ER et al. Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation. Bone Marrow Transplant 1993; 12: 149-154.
25. Nagler A, Slavin S, Yarkoni S et al. Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridization. Cancer Genet Cytogenet 1994; 73: 130-133.
26. Amiel A, Yarkoni S, Slavin S et al. Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization. Cancer Genet Cytogenet 1994; 76: 59-64.
27. Inazawa J, Nishigaki H, Takahira H. Rejoining between 9q+ and Philadelphia chromosomes results in normal-looking chromosomes 9 and 22 in Ph-negative chronic myelocytic leukemia. Hum Genet 1989; 83: 115-118.
28. Van der Plas D, Grosveld G, Hagemeijer A. Review of clinical cytogenetic and molecular aspects of Ph-negative CML. Cancer Genet Cytogenet 1991; 52: 143-156.
29. White AD, Sweeney MC. Detection of male cells in mixtures containing varying proportions of male and female cells by fluorescence in situ hybridization and G-banding. Cytometry 1993; 14: 9-15.
30. Tkachuk DC, Westbrook CA, Andreeff M et al. Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science 1990; 250: 559-562.
31. Pinkel D, Straume T, Gray VW. Cytogenetic analysis using quantitative high-resolution fluorescence hybridization. Proc Natl Acad Sci USA 1986; 83: 2934-2938.
32. Van Roy N, Laureys G, Versteeg R et al. High resolution fluorescence mapping of 46 DNA markers to the short arm of human chromosome 1. Genomics 1993; 11: 71-78.
33. Calabrese G, Sallese M, Stornaiuolo A et al. Chromosome mapping of the human arrestin (SAG) β-arrestin 2 (ARRB2), and β-adrenergic receptor kinase 2 (ADRBK2) genes. Genomics 1994; 23: 286-288.
34. Mezzanotte R, Ferrucci L, Vanni R, Bianchi U. Selective digestion of human metaphase chromosome by Alul restriction endonuclease. J Histochem Cytochem 1983; 31: 553-556.
35. Przepiorka D, Thomas ED, Durnam DM, Fisher L. Use of a probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of bone marrow transplant recipients. Am J Clin Pathol 1991; 95: 201-206.